Blood marker tracking may sharpen liver cancer prognosis
NCT ID NCT07204262
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 379 people with liver cancer to see if monitoring changes in blood markers over time could help doctors better predict how the disease will progress. Researchers combined these marker trends with patient information to build a more accurate risk model. The goal is to help personalize treatment decisions, but the study did not test a new treatment itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shenzhen Third People's Hospital
Shenzhen, Guangdong, 518112, China